MedTrace Logo

Comparison of Non-Invasive Blood Pressure (NIBP) Using the Biobeat Device with an Invasive Arterial Line Catheter

NCT04071015 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2025-03-26

No results posted yet for this study

Summary

In this clinical study the investigators will compare blood pressure measurements obtained using the non-invasive, wireless Biobeat monitoring device (both a wrist watch and a patch configuration) to an invasive arterial line catheter (radial or femoral) and a Swan Ganz Catheter in 20 patients immediately after cardiac surgery, at the cardiac intensive care unit.

Conditions

  • Blood Pressure
  • Heart Diseases

Interventions

DEVICE

Non-invasive monitoring

Comparing blood pressure measurement using the Biobeat non-invasive monitor to arterial line.

Sponsors & Collaborators

  • The Chaim Sheba Medical Center

    collaborator OTHER

  • Biobeat Technologies Ltd.

    lead INDUSTRY

Principal Investigators

  • Erez Kachel, MD · The Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-15
Primary Completion
2026-11-30
Completion
2026-12-31
FDA Device
Yes

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04071015 on ClinicalTrials.gov